IDEXX Laboratories Inc (IDXX, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories Inc has a market cap of $18.04 billion; its shares were traded at around $209.15 with a P/E ratio of 48.97 and P/S ratio of 8.36. IDEXX Laboratories Inc had annual average EBITDA growth of 13.10% over the past ten years. GuruFocus rated IDEXX Laboratories Inc the business predictability rank of 5-star.
For the last quarter IDEXX Laboratories Inc reported a revenue of $549.4 million, compared with the revenue of $506.1 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.2 billion, an increase of 12.4% from last year. For the last five years IDEXX Laboratories Inc had an average revenue growth rate of 10% a year.
The reported diluted earnings per share was $4.26 for the year, an increase of 44.9% from previous year. Over the last five years IDEXX Laboratories Inc had an EPS growth rate of 19.2% a year. The IDEXX Laboratories Inc enjoyed an operating margin of 22.2%, compared with the operating margin of 20.98% a year before. The 10-year historical median operating margin of IDEXX Laboratories Inc is 19.38%. The profitability rank of the company is 9 (out of 10).
At the end of the fiscal year, IDEXX Laboratories Inc has the cash and cash equivalents of $123.8 million, compared with $187.7 million in the previous year. The long term debt was $601.3 million, compared with $606.1 million in the previous year. The interest coverage to the debt is at a comfortable level of 14.6. IDEXX Laboratories Inc has a financial strength rank of 5 (out of 10).
At the current stock price of $209.15, IDEXX Laboratories Inc is traded at 100.4% premium to its historical median P/S valuation band of $104.35. The P/S ratio of the stock is 8.36, while the historical median P/S ratio is 4.17. The intrinsic value of the stock is $85.10 a share, according to GuruFocus DCF Calculator. The stock gained 16.09% during the past 12 months.
CEO Recent Trades:
- Chairman, President & CEO Jonathan W Ayers sold 47,714 shares of IDXX stock on 02/07/2019 at the average price of $206.53. The price of the stock has increased by 1.27% since.
Directors and Officers Recent Trades:
- Director Lawrence D Kingsley bought 2,405 shares of IDXX stock on 02/05/2019 at the average price of $208.68. The price of the stock has increased by 0.23% since.
- CORPORATE VICE PRESIDENT Giovani Twigge sold 997 shares of IDXX stock on 02/06/2019 at the average price of $209.08. The price of the stock has increased by 0.03% since.
For the complete 20-year historical financial data of IDXX, click here.
